S100B modulates the hemodynamic response to norepinephrine stimulation

American Journal of Hypertension

Volumn 22, Issue 10, 2009, Pages 1048-1053

  Tsoporis, James N ^a   Overgaard, Christopher B ^a   Izhar, Shehla ^a   Parker, Thomas G ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AHNAK PHOSPHOPROTEIN; CALCIUM; NORADRENALIN; PHOSPHOPROTEIN; PROTEIN S100B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE REGULATION; CALCIUM CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HEART MUSCLE CELL; HEART RATE; HEART VENTRICLE HYPERTROPHY; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RIBONUCLEASE PROTECTION ASSAY; SMOOTH MUSCLE FIBER;

ANIMALS; CALCIUM; CARDIOMEGALY; DISEASE MODELS, ANIMAL; HEMODYNAMICS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MUSCLE CELLS; MYOCYTES, SMOOTH MUSCLE; NEOPLASM PROTEINS; NERVE GROWTH FACTORS; NOREPINEPHRINE; RNA, MESSENGER; S100 PROTEINS;

EID: 70349445277     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.145     Document Type: Article

References (27)

1. Parker TG. Molecular biology of cardiac growth and hypertrophy. Herz 1993; 18:245-255.
2. Hoshijima M, Chien KR. Mixed signals in heart failure: cancer rules. J Clin Invest 2002; 109:849-855.
3. Yamamoto S, Yang G, Zablocki D, Liu J, Hong C, Kim SJ, Soler S, Odashima M, Thaisz J, Yehia G, Molina CA, Yatani A, Vatner DE, Vatner SF, Sadoshima J. Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. J Clin Invest 2003; 111:1463-1474.
4. Tsoporis JN, Marks A, Kahn HJ, Butany JW, Liu P P, O'Hanlon D, Parker TG. S100β inhibits α1-adrenergic induction of the hypertrophic phenotype in cardiac myocytes. J Biol Chem 1997; 272:31915-31921.
5. Tsoporis JN, Marks A, Kahn HJ, Butany JW, Liu PP, O'Hanlon D, Parker TG. Inhibiton of norepinephrine-induced cardiac hypertrophy in s100pS transgenic mice. J Clin Invest 1998; 102:1609-1616.
6. Tsoporis JN, Marks A, Haddad A, Dawood F, Liu PP, Parker TG. S100B expression modulates left ventricular remodeling after myocardial infarction in mice. Circulation 2005; 111598-111606
7. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003; 60:540-551.
8. Kahn HJ, Baumal R, Van Eldik LJ, Dunn RJ, Marks A. mmunoreactivity of S100pSin heart, skeletal muscle, and kidney in chronic lung disease: possible induction by cAMP. Mod Pathol 1991; 4:698-701.
9. Sakaguchi T, Yan SF, Yan SD, Belov D, Rong LL, Sousa M, Andrassy M, Marso SP, Duda S, Arnold B, Liliensiek B, Nawroth PP, Stern DM, Schmidt AM, Naka Y. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest 2003; 111:959-972.
10. Zhou Z, Wang K, Penn MS, Marso SP, Lauer MA, Forudi F, Zhou X, Qu W, Lu Y, Stern DM, Schmidt AM, Lincoff AM, Topol EJ. Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation 2003; 107: 2238-2243.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
12. Communal C, Singh K, Pimente DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the pS-adrenergic pathway. Circulation 1998; 98:1329-1334.
13. Owens GK, Loeb A, Gordon D, Thompson MM. Expression of smooth muscle-specifica-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation J Cell Biol 1986; 102:343-352.
14. Leclerc PC, Proulx CD, Arguin G, Bélanger S, Gobeil F, Escher E, Leduc R, Guillemette G. Ascorbic acid decreases the binding affinity of the AT1 receptor for angiotensin II. Am J Hypertens 2008; 21:67-71.
15. Tsoporis J, Fields N, Lee RM, Leenen FH. Effects of the arterial vasodilator minoxidil on cardiovascular structure and sympathetic activity in spontaneously hypertensive rats. J Hypertens 1993; 11:1337-1345.
16. Tsoporis J, Fields N, Lee RM, Leenen FH. Opposite effects of arteria vasodilators on cardiac vs. arterial hypertrophy and sympathetic activity in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1991; 17 Suppl 2:S169-S171.
17. Zhao M, Hagler HK, Muntz KH. Regulation ofa1-,pS1-, and (32-adrenergic receptors in rat heart by norepinephrine. Am J Physiol 1996; 271: H1762-H1768.
18. Desjardins JF, Pourdjabbar A, Quan A, Leong-Poi H, Teichert-Kuliszewska K, Verma S, Par er TG. Lack of S100A1 in mice confers a gender-dependent hypertensive phenotype and increased mortality after myocardial infarction. Am J Physiol Heart Circ Physiol 2009; 296:H1457-H1465.
19. Most P, Seifert H, Gao E, Funakoshi H, Völkers M, Heierhorst J, Remppis A, Pleger ST, DeGeorge BR, Eckhart AD, Feldman AM, Koch WJ Cardiac S100A1 protein levels determine contractile performance and propensity to ward heart failure after myocardial infarction. Circulation 2006; 114:1258-1268.
20. Tsoporis JN, Marks A, Van Eldik LJ, O'Hanlon D, Parker TG. Regulation of the S100B gene by a1-adrenergic stimulation in cardiac myocytes. Am J Physiol Heart Circ Physiol 2003; 284:H193-H203.
21. Zhu WZ, Kwan CY, Han C Ca2+-dependence of vasoconstriction mediated by a1A-adrenoceptors in perfused rat hindlimb a pharmacological approach. Life Sci 1998; 63:PL 89-PL 94.
22. Erami C, Zhang H, Ho JG, French DM, Faber JE.a(1)-Adrenoceptor stimulation directly induces growth of vascular wall in vivo. Am J Physiol Heart Circ Physiol 2002; 283:H1577-H1587.
23. Caramelo C, Okada K, Tsai P Schrier RW. Mechanisms of the vascular effect of pressor hormones. Am J Cardiol 1988; 62:47G-53G.
24. Xiong Z, O'Hanlon D, Becker LE, Roder J, MacDonald JF, Marks A. Enhanced calcium transients in glial cells in neonatal cerebellar cultures derived from S100B null mice. Exp Cell Res 2000; 257:281-289
25. Haase H, Alvarez J, Petzhold D, Doller A, Behlke J, Erdmann J, Hetzer R Regitz-Zagrosek V, Vassort G, Morano . Ahnak is critical for cardiac Ca(V)1.2 calcium channel function and its (3-adrenergic regulation. FASEB J 2005; 19: 1969-1977.
26. Lee H, You JO, Ha KS, Bae DS, Suh PG, Rhee SG, Bae YS. AHNAK-mediated activation of phospholipase C-y1 through protein kinase C J Biol Chem 2004; 279:26645-26653.
27. Gentil BJ, Delphin C, Mbele GO, Deloulme JC, Ferro M, Garin J, Baudier J. The giant protein AHNAK is a specific target for the calcium-and zinc-binding S100B protein: potential implications for Ca2+ homeostasis regulation by S100B. J Biol Chem 2001; 276:23253-23261.